Order Article Reprints

Bhise A, Park H, Lee W, Sarkar S, Ha YS, Rajkumar S, Nam B, Lim JE, Huynh PT, Lee K, et al. Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging. Pharmaceutics. 2022; 14(8):1677. https://doi.org/10.3390/pharmaceutics14081677

Bhise, Abhinav, Hyun Park, Woonghee Lee, Swarbhanu Sarkar, Yeong Su Ha, Subramani Rajkumar, Bora Nam, Jeong Eun Lim, Phuong Tu Huynh, Kiwoong Lee, and et al. 2022. "Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging" Pharmaceutics 14, no. 8: 1677. https://doi.org/10.3390/pharmaceutics14081677

Bhise, A., Park, H., Lee, W., Sarkar, S., Ha, Y. S., Rajkumar, S., Nam, B., Lim, J. E., Huynh, P. T., Lee, K., Son, J.-Y., Kim, J. Y., Lee, K. C., & Yoo, J. (2022). Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging. Pharmaceutics, 14(8), 1677. https://doi.org/10.3390/pharmaceutics14081677